Hypersensitivity pneumonitis

Tracy Prematta, Jennifer Toth, Timothy Craig

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Hypersensitivity pneumonitis (HP), also known as extrinsic allergic alveolitis, encompasses a group of pulmonary disorders characterized by immune response to a variety of antigens derived from medications, chemicals, microorganisms, and plant and animal proteins. The first cases of HP were described in occupational or hobbyist settings, but HP secondary to home exposures is becoming more common. The clinical presentation has a wide range, from acute HP, which often presents as an acute febrile illness, to chronic HP, with insidious progression of dyspnea and systemic complaints. The development of HP requires TH1 cell, cytotoxic lymphocyte, and IgG immune responses. TH2 cells and IgE are not involved. The diagnosis of HP must be made clinically with consistent history and known appropriate antigen exposure. Supportive evidence can be gathered from serologic tests (including serum precipitans), radiographic evaluation, bronchoscopy with BAL, biopsy, and natural or direct antigen inhalation challenges. Although systemic corticosteroids may improve acute exacerbations, removal from the inciting antigen is paramount in the appropriate treatment of HP. Unfortunately, irreversible pulmonary fibrosis can develop in long-standing HP leading to significant morbidity and mortality, highlighting the need for early detection and antigen avoidance.

Original languageEnglish (US)
Title of host publicationChallenging Cases in Allergy and Immunology
PublisherHumana Press
Pages71-86
Number of pages16
ISBN (Print)9781603274425
DOIs
StatePublished - Dec 1 2009

Fingerprint

Extrinsic Allergic Alveolitis
Antigens
Dimercaprol
Plant Proteins
Pulmonary Fibrosis
Immune System Diseases
Bronchoscopy
Serologic Tests
Dyspnea
Immunoglobulin E
Inhalation
Adrenal Cortex Hormones
Chronic Disease
Fever
Immunoglobulin G
History
Lymphocytes
Morbidity

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Prematta, T., Toth, J., & Craig, T. (2009). Hypersensitivity pneumonitis. In Challenging Cases in Allergy and Immunology (pp. 71-86). Humana Press. https://doi.org/10.1007/978-1-60327-443-2_6
Prematta, Tracy ; Toth, Jennifer ; Craig, Timothy. / Hypersensitivity pneumonitis. Challenging Cases in Allergy and Immunology. Humana Press, 2009. pp. 71-86
@inbook{d2d12910d8a54fe39f2acee3751070dd,
title = "Hypersensitivity pneumonitis",
abstract = "Hypersensitivity pneumonitis (HP), also known as extrinsic allergic alveolitis, encompasses a group of pulmonary disorders characterized by immune response to a variety of antigens derived from medications, chemicals, microorganisms, and plant and animal proteins. The first cases of HP were described in occupational or hobbyist settings, but HP secondary to home exposures is becoming more common. The clinical presentation has a wide range, from acute HP, which often presents as an acute febrile illness, to chronic HP, with insidious progression of dyspnea and systemic complaints. The development of HP requires TH1 cell, cytotoxic lymphocyte, and IgG immune responses. TH2 cells and IgE are not involved. The diagnosis of HP must be made clinically with consistent history and known appropriate antigen exposure. Supportive evidence can be gathered from serologic tests (including serum precipitans), radiographic evaluation, bronchoscopy with BAL, biopsy, and natural or direct antigen inhalation challenges. Although systemic corticosteroids may improve acute exacerbations, removal from the inciting antigen is paramount in the appropriate treatment of HP. Unfortunately, irreversible pulmonary fibrosis can develop in long-standing HP leading to significant morbidity and mortality, highlighting the need for early detection and antigen avoidance.",
author = "Tracy Prematta and Jennifer Toth and Timothy Craig",
year = "2009",
month = "12",
day = "1",
doi = "10.1007/978-1-60327-443-2_6",
language = "English (US)",
isbn = "9781603274425",
pages = "71--86",
booktitle = "Challenging Cases in Allergy and Immunology",
publisher = "Humana Press",
address = "United States",

}

Prematta, T, Toth, J & Craig, T 2009, Hypersensitivity pneumonitis. in Challenging Cases in Allergy and Immunology. Humana Press, pp. 71-86. https://doi.org/10.1007/978-1-60327-443-2_6

Hypersensitivity pneumonitis. / Prematta, Tracy; Toth, Jennifer; Craig, Timothy.

Challenging Cases in Allergy and Immunology. Humana Press, 2009. p. 71-86.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Hypersensitivity pneumonitis

AU - Prematta, Tracy

AU - Toth, Jennifer

AU - Craig, Timothy

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Hypersensitivity pneumonitis (HP), also known as extrinsic allergic alveolitis, encompasses a group of pulmonary disorders characterized by immune response to a variety of antigens derived from medications, chemicals, microorganisms, and plant and animal proteins. The first cases of HP were described in occupational or hobbyist settings, but HP secondary to home exposures is becoming more common. The clinical presentation has a wide range, from acute HP, which often presents as an acute febrile illness, to chronic HP, with insidious progression of dyspnea and systemic complaints. The development of HP requires TH1 cell, cytotoxic lymphocyte, and IgG immune responses. TH2 cells and IgE are not involved. The diagnosis of HP must be made clinically with consistent history and known appropriate antigen exposure. Supportive evidence can be gathered from serologic tests (including serum precipitans), radiographic evaluation, bronchoscopy with BAL, biopsy, and natural or direct antigen inhalation challenges. Although systemic corticosteroids may improve acute exacerbations, removal from the inciting antigen is paramount in the appropriate treatment of HP. Unfortunately, irreversible pulmonary fibrosis can develop in long-standing HP leading to significant morbidity and mortality, highlighting the need for early detection and antigen avoidance.

AB - Hypersensitivity pneumonitis (HP), also known as extrinsic allergic alveolitis, encompasses a group of pulmonary disorders characterized by immune response to a variety of antigens derived from medications, chemicals, microorganisms, and plant and animal proteins. The first cases of HP were described in occupational or hobbyist settings, but HP secondary to home exposures is becoming more common. The clinical presentation has a wide range, from acute HP, which often presents as an acute febrile illness, to chronic HP, with insidious progression of dyspnea and systemic complaints. The development of HP requires TH1 cell, cytotoxic lymphocyte, and IgG immune responses. TH2 cells and IgE are not involved. The diagnosis of HP must be made clinically with consistent history and known appropriate antigen exposure. Supportive evidence can be gathered from serologic tests (including serum precipitans), radiographic evaluation, bronchoscopy with BAL, biopsy, and natural or direct antigen inhalation challenges. Although systemic corticosteroids may improve acute exacerbations, removal from the inciting antigen is paramount in the appropriate treatment of HP. Unfortunately, irreversible pulmonary fibrosis can develop in long-standing HP leading to significant morbidity and mortality, highlighting the need for early detection and antigen avoidance.

UR - http://www.scopus.com/inward/record.url?scp=84891451764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891451764&partnerID=8YFLogxK

U2 - 10.1007/978-1-60327-443-2_6

DO - 10.1007/978-1-60327-443-2_6

M3 - Chapter

AN - SCOPUS:84891451764

SN - 9781603274425

SP - 71

EP - 86

BT - Challenging Cases in Allergy and Immunology

PB - Humana Press

ER -

Prematta T, Toth J, Craig T. Hypersensitivity pneumonitis. In Challenging Cases in Allergy and Immunology. Humana Press. 2009. p. 71-86 https://doi.org/10.1007/978-1-60327-443-2_6